Similar articles

• [H-B-VAX II hepatitis B vaccine (recombinant) produced at the MSD Research Laboratories. Description of the vaccine].

  [No authors listed] [No authors listed] Przegl Epidemiol. 1991;45(1-2):3-10. Przegl Epidemiol. 1991. PMID: 1839076 Polish. No abstract available.
• Production and immunological analysis of recombinant hepatitis B vaccine.

  Emini EA, Ellis RW, Miller WJ, McAleer WJ, Scolnick EM, Gerety RJ. Emini EA, et al. J Infect. 1986 Jul;13 Suppl A:3-9. doi: 10.1016/s0163-4453(86)92563-6. J Infect. 1986. PMID: 2427590
• Prevention of hepatitis B by recombinant DNA hepatitis B vaccine.

  Schalm SW, Heijtink RA. Schalm SW, et al. Neth J Med. 1986;29(2):42-8. Neth J Med. 1986. PMID: 3951652 No abstract available.
• Significance of pre-S2 peptide of hepatitis B virus: should it be in the vaccine?

  Hellström UB, Sylvan SP. Hellström UB, et al. Prog Med Virol. 1988;35:76-106. Prog Med Virol. 1988. PMID: 2971987 Review. No abstract available.
• [Vaccines against hepatitis B].

  Viazov SO. Viazov SO. Vopr Virusol. 1984 Nov-Dec;29(6):656-63. Vopr Virusol. 1984. PMID: 6396952 Review. Russian. No abstract available.